These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290 [TBL] [Abstract][Full Text] [Related]
54. Inotropes and beta-blockers: is there a need for new guidelines? Bristow MR; Shakar SF; Linseman JV; Lowes BD J Card Fail; 2001 Jun; 7(2 Suppl 1):8-12. PubMed ID: 11605160 [TBL] [Abstract][Full Text] [Related]
55. Cardioprotection with beta-blockers: myths, facts and Pascal's wager. Messerli FH; Bangalore S; Yao SS; Steinberg JS J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791 [TBL] [Abstract][Full Text] [Related]
56. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function. Giles TD Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666 [TBL] [Abstract][Full Text] [Related]
57. Pharmacogenetics and response to beta-adrenergic receptor antagonists in heart failure. Muszkat M; Stein CM Clin Pharmacol Ther; 2005 Mar; 77(3):123-6. PubMed ID: 15735606 [No Abstract] [Full Text] [Related]